Relmada Therapeutics shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $931k | 225k | 4.14 |
| 2023-09-30 | $15k | 5.0k | 3.00 |
| 2023-06-30 | $586k | 238k | 2.46 |
| 2023-03-31 | $576k | 255k | 2.26 |
| 2022-12-31 | $835k | 239k | 3.49 |
| 2022-09-30 | $8.8M | 237k | 36.87 |
| 2022-06-30 | $4.6M | 239k | 19.17 |
| 2022-03-31 | $6.5M | 239k | 27.11 |
| 2021-12-31 | $230k | 10k | 22.59 |
| 2021-09-30 | $432k | 17k | 26.21 |
| 2021-06-30 | $501k | 16k | 31.96 |
| 2021-03-31 | $563k | 16k | 35.13 |
| 2020-12-31 | $364k | 12k | 31.39 |
| 2020-09-30 | $294k | 7.8k | 37.65 |
| 2020-06-30 | $322k | 7.1k | 45.18 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft